Marilyn Albert, PhD

Trials

Studies that name Marilyn Albert, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:53 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06919926 · Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults

  Johns Hopkins University · active not recruiting · Hippocampal Overactivity, Dementia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
  R01AG061091 · NIA · AGENEBIO, INC. · PI RICHARD Charles MOHS · fiscal years 2018 to 2022
  Named on NCT06919926